Advocacy at a Glance STEVEN GROSSMAN 10/28/16 Advocacy at a Glance STEVEN GROSSMAN 10/28/16 Down-Ballot Congressional Races: Another Post-Election Unknown Read More Advocacy at a Glance STEVEN GROSSMAN 10/21/16 Advocacy at a Glance STEVEN GROSSMAN 10/21/16 Presidential Transition Planning Underway Read More Advocacy at a Glance STEVEN GROSSMAN 10/14/16 Advocacy at a Glance STEVEN GROSSMAN 10/14/16 Congress to Return November 14; Government Funding Top Priority Read More Advocacy at a Glance STEVEN GROSSMAN 10/1/16 Advocacy at a Glance STEVEN GROSSMAN 10/1/16 A CR Gets Passed ... But Has Fiscal Implications Read More Advocacy at a Glance STEVEN GROSSMAN 10/1/16 Advocacy at a Glance STEVEN GROSSMAN 10/1/16 CR through December 9 Passes; Congress in Recess Read More Advocacy at a Glance STEVEN GROSSMAN 9/23/16 Advocacy at a Glance STEVEN GROSSMAN 9/23/16 Continuing Resolution Still in Negotiations; One Week to Go or Else Read More Advocacy at a Glance STEVEN GROSSMAN 9/16/16 Advocacy at a Glance STEVEN GROSSMAN 9/16/16 Alliance District Lobby Days Planned for Mid-October. Please Participate Read More Advocacy at a Glance STEVEN GROSSMAN 9/9/16 Advocacy at a Glance STEVEN GROSSMAN 9/9/16 CDRH Director Shuren’s Presentation Well Received. Read More Advocacy at a Glance STEVEN GROSSMAN 8/28/16 Advocacy at a Glance STEVEN GROSSMAN 8/28/16 Congress Returns Soon; Unclear How Long It Will Stay Read More Advocacy at a Glance STEVEN GROSSMAN 8/20/16 Advocacy at a Glance STEVEN GROSSMAN 8/20/16 Appropriations Status Unchanged Read More Advocacy at a Glance STEVEN GROSSMAN 8/15/16 Advocacy at a Glance STEVEN GROSSMAN 8/15/16 Key Congressional Decisions: CR or Omnibus; December or March Read More Advocacy at a Glance STEVEN GROSSMAN 7/29/16 Advocacy at a Glance STEVEN GROSSMAN 7/29/16 Status of Appropriations Read More Advocacy at a Glance STEVEN GROSSMAN 7/22/16 Advocacy at a Glance STEVEN GROSSMAN 7/22/16 FDA Issues Strategic Plan for Food Safety and Veterinary Medicine Read More Advocacy at a Glance STEVEN GROSSMAN 7/15/16 Advocacy at a Glance STEVEN GROSSMAN 7/15/16 Congress’ Summer Adjournment; Back in September Read More Advocacy at a Glance STEVEN GROSSMAN 7/8/16 Advocacy at a Glance STEVEN GROSSMAN 7/8/16 One Week until Congress’ Summer Adjournment Read More Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Congressional Calendar Leaves Little Time for Legislating Read More Advocacy at a Glance STEVEN GROSSMAN 6/17/16 Advocacy at a Glance STEVEN GROSSMAN 6/17/16 Senate Considers CJS Appropriations Without Ag/FDA Read More Advocacy at a Glance STEVEN GROSSMAN 6/10/16 Advocacy at a Glance STEVEN GROSSMAN 6/10/16 Speaker Ryan Changes Floor Rules to Expedite Appropriations Bills Read More Advocacy at a Glance STEVEN GROSSMAN 6/3/16 Advocacy at a Glance STEVEN GROSSMAN 6/3/16 Appropriations Process: Pace is Uncertain When Congress Returns Read More Advocacy at a Glance STEVEN GROSSMAN 5/20/16 Advocacy at a Glance STEVEN GROSSMAN 5/20/16 Senate Ag/FDA Appropriations Committee Tops House by $6 Million Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 10/28/16 Advocacy at a Glance STEVEN GROSSMAN 10/28/16 Down-Ballot Congressional Races: Another Post-Election Unknown Read More
Advocacy at a Glance STEVEN GROSSMAN 10/21/16 Advocacy at a Glance STEVEN GROSSMAN 10/21/16 Presidential Transition Planning Underway Read More
Advocacy at a Glance STEVEN GROSSMAN 10/14/16 Advocacy at a Glance STEVEN GROSSMAN 10/14/16 Congress to Return November 14; Government Funding Top Priority Read More
Advocacy at a Glance STEVEN GROSSMAN 10/1/16 Advocacy at a Glance STEVEN GROSSMAN 10/1/16 A CR Gets Passed ... But Has Fiscal Implications Read More
Advocacy at a Glance STEVEN GROSSMAN 10/1/16 Advocacy at a Glance STEVEN GROSSMAN 10/1/16 CR through December 9 Passes; Congress in Recess Read More
Advocacy at a Glance STEVEN GROSSMAN 9/23/16 Advocacy at a Glance STEVEN GROSSMAN 9/23/16 Continuing Resolution Still in Negotiations; One Week to Go or Else Read More
Advocacy at a Glance STEVEN GROSSMAN 9/16/16 Advocacy at a Glance STEVEN GROSSMAN 9/16/16 Alliance District Lobby Days Planned for Mid-October. Please Participate Read More
Advocacy at a Glance STEVEN GROSSMAN 9/9/16 Advocacy at a Glance STEVEN GROSSMAN 9/9/16 CDRH Director Shuren’s Presentation Well Received. Read More
Advocacy at a Glance STEVEN GROSSMAN 8/28/16 Advocacy at a Glance STEVEN GROSSMAN 8/28/16 Congress Returns Soon; Unclear How Long It Will Stay Read More
Advocacy at a Glance STEVEN GROSSMAN 8/20/16 Advocacy at a Glance STEVEN GROSSMAN 8/20/16 Appropriations Status Unchanged Read More
Advocacy at a Glance STEVEN GROSSMAN 8/15/16 Advocacy at a Glance STEVEN GROSSMAN 8/15/16 Key Congressional Decisions: CR or Omnibus; December or March Read More
Advocacy at a Glance STEVEN GROSSMAN 7/29/16 Advocacy at a Glance STEVEN GROSSMAN 7/29/16 Status of Appropriations Read More
Advocacy at a Glance STEVEN GROSSMAN 7/22/16 Advocacy at a Glance STEVEN GROSSMAN 7/22/16 FDA Issues Strategic Plan for Food Safety and Veterinary Medicine Read More
Advocacy at a Glance STEVEN GROSSMAN 7/15/16 Advocacy at a Glance STEVEN GROSSMAN 7/15/16 Congress’ Summer Adjournment; Back in September Read More
Advocacy at a Glance STEVEN GROSSMAN 7/8/16 Advocacy at a Glance STEVEN GROSSMAN 7/8/16 One Week until Congress’ Summer Adjournment Read More
Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Congressional Calendar Leaves Little Time for Legislating Read More
Advocacy at a Glance STEVEN GROSSMAN 6/17/16 Advocacy at a Glance STEVEN GROSSMAN 6/17/16 Senate Considers CJS Appropriations Without Ag/FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 6/10/16 Advocacy at a Glance STEVEN GROSSMAN 6/10/16 Speaker Ryan Changes Floor Rules to Expedite Appropriations Bills Read More
Advocacy at a Glance STEVEN GROSSMAN 6/3/16 Advocacy at a Glance STEVEN GROSSMAN 6/3/16 Appropriations Process: Pace is Uncertain When Congress Returns Read More
Advocacy at a Glance STEVEN GROSSMAN 5/20/16 Advocacy at a Glance STEVEN GROSSMAN 5/20/16 Senate Ag/FDA Appropriations Committee Tops House by $6 Million Read More
